Goodman & Nekvasil, P.A., May Recover Investor Losses – Vaccinogen, Inc. (VGEN) Suspended by the SEC from Trading
In suspending Vaccinogen, Inc. (VGEN) stock from trading, the SEC explained that Vaccinogen, Inc. (VGEN) is delinquent in its periodic filings with the Commission, having not filed any periodic reports since it filed a Form 10-Q for the period ended September 30, 2015. Goodman & Nekvasil, P.A., a Clearwater, Florida, law firm with a national practice representing victimized investors, continues to investigate brokerage firms that placed elderly retirees and other conservative investors in high-risk investments, including Vaccinogen, Inc. (VGEN).
Even though stock issued by Vaccinogen, Inc. (VGEN) had considerable risk, overzealous brokers, brokerage firms and registered investment advisors have nonetheless recommended Vaccinogen, Inc. (VGEN) and these types of investments to conservative investors seeking income. We believe that investors Vaccinogen, Inc. (VGEN) have lost a significant amount or all of their investment.
Goodman & Nekvasil, P.A., has filed hundreds of cases against brokerage firms selling high-risk investments such as Vaccinogen, Inc. (VGEN), and has recovered more than $300 million dollars on behalf of victimized investors. We allege in these cases that these investment recommendations were unsuitable for our clients in view of their financial situation, needs and investment objectives. All our cases are handled on a purely contingency fee basis.
You may have the right to recover your losses from the brokerage firm that sold Vaccinogen, Inc. (VGEN) and other high-risk investments to you. We strongly recommend that you act quickly, however, because statutes of limitation can be short in securities cases.
Kalju Nekvasil, Esq., formerly regional counsel with the NASD, now known as FINRA, has practiced in this area of the law for more than 35 years. We would like to discuss the possibility of your retaining our firm to represent you in an arbitration action.
There is no charge for an evaluation of your case. Further, we handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee. Unless you recover any money, you pay us nothing, not even the costs and expenses which the firm will advance on your behalf. Finally, the filing of such a case should not affect your ownership of these investments in any way.
If you incurred losses on your investment in Vaccinogen, Inc. (VGEN) and/or other high-risk investments and would like your case evaluated by a securities attorney (again, there is no charge for an evaluation and all cases are handled on a purely contingency fee basis), please contact us.
Keywords: Vaccinogen, SEC, Stock, Suspension, SEC, Fraud, Attorney, Broker, Brokerage, Firm, Brokerage Firm, Invest, Lawyer, Securities Lawyer, Goodman and Nekvasil, Nekvasil, Goodman, Investor, Investment, Financial, Financial Services, Securities